Emergency Opioid Antagonist Products and Resources

The Florida Department of Children and Families, through its Substance Abuse and Mental Health division, is soliciting proposals under RFP 2627 020 to procure a provider for its Overdose Prevention Program. The selected provider will supply multiple formulations of emergency opioid antagonist products, such as naloxone, and related resources to approximately 1,500 authorized enrolled distributors throughout Florida. The contract is anticipated to run for one year, starting no later than November 30, 2026, and requires the provider to be fully operational on day one with no ramp-up period. Key deliverables include the use of a dedicated ordering and reporting portal and the provision of two-day shipping at no additional cost, with overnight shipping available for emergencies. The provider must ensure that all products have at least 30 months of shelf-life remaining at the time of shipment and must be the most recently manufactured versions available. Payment is structured as a fixed rate, with consolidated monthly invoices submitted for the Community and HEROS programs. Evaluation for the award is based on a combination of programmatic scoring, which emphasizes service capability, project approach, and prior similar projects, as well as financial scoring. The contract mandates strict compliance with Florida Statutes, the State Opioid Response Grant terms, and federal regulations regarding grant management and confidentiality.